Skip to main content
TipRanks
Go Ultimate75% OFF

HLB Life Science Co.,Ltd. (067630) Income Statement

HLB Life Science Co.,Ltd. Income Statement

Last quarter (Q4 2025), HLB Life Science Co.,Ltd.'s total revenue was ₩10.95B, a decrease of 61.83% from the same quarter last year. In Q4, HLB Life Science Co.,Ltd.'s net income was ₩20.08B. See HLB Life Science Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
₩ 45.75B₩ 102.24B₩ 97.99B₩ 99.59B₩ 53.49B
₩ -494.41M₩ -2.19B₩ -748.57M₩ -3.05B₩ -5.54B
₩ 20.53B₩ 22.63B₩ 23.78B₩ 17.11B₩ 12.94B
Depreciation and Amortization₩ 5.25B₩ 5.90B₩ 7.70B₩ 5.22B₩ 2.48B
₩ -83.58B₩ 25.87B₩ 22.84B₩ -45.75B₩ -49.88B
₩ -21.02B₩ -24.82B₩ -24.53B₩ -20.16B₩ -18.48B
₩ -79.54B₩ 27.97B₩ 18.03B₩ -40.68B₩ -35.14B
₩ -100.57B₩ 3.15B₩ -6.50B₩ -60.84B₩ -53.62B
₩ -99.79B₩ 6.14B₩ -5.98B₩ -54.36B₩ -49.29B
Per Share Metrics
Basic EPS₩ -818.56₩ 56.64₩ -54.79₩ -533.76₩ -467.10
Diluted EPS₩ -818.56₩ 56.64₩ -54.79₩ -533.76₩ -467.10
Weighted Average Shares Outstanding121.92M108.37M106.84M106.84M106.84M
Weighted Average Shares Outstanding (Diluted)121.92M108.37M106.84M106.84M106.84M

Currency in KRW

HLB Life Science Co.,Ltd. Earnings and Revenue History

-120B0120B240B-240 %-120 %0 %120 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin